Xiangyu Medical Co.,Ltd (688626.SS)
CNY 38.44
(7.55%)
CNY 38.44
(7.55%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -628.32 Million CNY | 11.4% |
| 2022 | -709.16 Million CNY | 14.21% |
| 2021 | -826.58 Million CNY | -89.04% |
| 2020 | -437.24 Million CNY | -20.79% |
| 2019 | -361.99 Million CNY | -1740.67% |
| 2018 | -19.66 Million CNY | -122.26% |
| 2017 | -8.84 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -402.05 Million CNY | 11.17% |
| 2024 Q1 | -463.37 Million CNY | 26.25% |
| 2024 Q2 | -446.48 Million CNY | 3.64% |
| 2023 Q1 | -771.31 Million CNY | -8.76% |
| 2023 FY | -628.32 Million CNY | 11.4% |
| 2023 Q4 | -628.32 Million CNY | -9.83% |
| 2023 Q2 | -632.47 Million CNY | 18.0% |
| 2023 Q3 | -572.09 Million CNY | 9.55% |
| 2022 Q3 | -719.59 Million CNY | 3.58% |
| 2022 Q2 | -746.29 Million CNY | 0.06% |
| 2022 Q1 | -746.77 Million CNY | 9.65% |
| 2022 FY | -709.16 Million CNY | 14.21% |
| 2022 Q4 | -709.16 Million CNY | 1.45% |
| 2021 FY | -826.58 Million CNY | -89.04% |
| 2021 Q4 | -826.58 Million CNY | -7.58% |
| 2021 Q3 | -768.33 Million CNY | 4.13% |
| 2021 Q2 | -801.44 Million CNY | 46.81% |
| 2021 Q1 | -1.5 Billion CNY | -244.63% |
| 2020 Q3 | - CNY | 100.0% |
| 2020 Q1 | 364.28 Million CNY | 200.0% |
| 2020 FY | -437.24 Million CNY | -20.79% |
| 2020 Q4 | -437.24 Million CNY | 0.0% |
| 2020 Q2 | -407.13 Million CNY | -211.76% |
| 2019 FY | -361.99 Million CNY | -1740.67% |
| 2019 Q4 | -364.28 Million CNY | 0.0% |
| 2018 FY | -19.66 Million CNY | -122.26% |
| 2017 FY | -8.84 Million CNY | 0.0% |